首页|血脂康胶囊联合阿托伐他汀治疗高脂血症患者的效果

血脂康胶囊联合阿托伐他汀治疗高脂血症患者的效果

扫码查看
目的:观察血脂康胶囊联合阿托伐他汀治疗高脂血症患者的效果.方法:选取 2021 年 11 月至 2023 年 11 月该院收治的100例高脂血症患者进行前瞻性研究,按照随机数字表法将其分为对照组和研究组各50例.对照组采用阿托伐他汀治疗,研究组在对照组基础上联合血脂康胶囊治疗,比较两组临床疗效,治疗前后血清炎性因子[C反应蛋白(CRP)、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-ɑ)]、脂代谢指标[总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、三酰甘油(TG)]、血液流变学指标(血浆黏度、全血低切黏度)水平,以及不良反应发生率.结果:研究组治疗总有效率为 96.00%(48/50),高于对照组的84.00%(42/50),差异有统计学意义(P<0.05);治疗后,研究组CRP、TNF-α和IL-6水平均低于对照组,差异有统计学意义(P<0.05);治疗后,研究组TG、TC、LDL-C水平均低于对照组,HDL-C水平高于对照组,差异有统计学意义(P<0.05);治疗后,研究组血浆黏度、全血低切黏度均低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:血脂康胶囊联合阿托伐他汀治疗高脂血症患者可提高治疗总有效率,改善脂代谢指标水平,降低血清炎性因子和血液流变学指标水平,效果优于单纯阿托伐他汀治疗.
Effects of Xuezhikang capsules combined with Atorvastatin in treatment of patients with hyperlipidemia
Objective:To observe effects of Xuezhikang capsules combined with Atorvastatin in treatment of patients with hyperlipidemia.Methods:A prospective study was conducted on 100 patients with hyperlipidemia admitted to the hospital from November 2021 to November 2023.According to the random number table method,they were divided into control group and study group,50 cases in each group.The control group was treated with Atorvastatin,while the study group was treated with Xuezhikang capsules on the basis of that of the control group.The clinical efficacy,the levels of serum inflammatory factors[C-reactive protein(CRP),interleukin-6(IL-6)and tumor necrosis factor-ɑ(TNF-ɑ)],lipid metabolism indexes[total cholesterol(TC),low density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C),triglyceride(TG)]and hemorheology indexes(plasma viscosity,whole blood low shear viscosity),and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of treatment in the study group was 96.00%(48/50),which was higher than 84.00%(42/50)in the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of CRP,TNF-α and IL-6 in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of TG,TC and LDL-C in the study group were lower than those in the control group,the level of HDL-C was higher than that in the control group,and the differences were statistically significant(P<0.05).After the treatment,the plasma viscosity and the whole blood low shear viscosity in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Xuezhikang capsules combined with Atorvastatin can improve the total effective rate of treatment,improve the levels of lipid metabolism indexes,and reduce the levels of serum inflammatory factors and hemorheology indexes in the patients with hyperlipidemia.Moreover,it is superior to simple Atorvastatin treatment.

Xuezhikang capsulesAtorvastatinHyperlipidemiaLipid metabolismInflammatory factorHemorheologyAdverse reaction

许晓迟、李烨、陈钦灿、胡浩

展开 >

厦门市海沧区石塘社区卫生服务中心全科,福建 厦门 361000

厦门市海沧区石塘社区卫生服务中心放射科,福建 厦门 361000

血脂康胶囊 阿托伐他汀 高脂血症 脂代谢 炎性因子 血液流变学 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(15)